Cardiovascular / Cardiology
Earlier Menopause Could Increase Cardiovascular Risks
Women who experience menopause earlier are at greater risk for cardiovascular issues such as heart disease and stroke and even have greater all-cause mortality rates than women who experience menopause nearer the average age of 51, according to a new study published in the Journal of the American Medical Association Cardiology. The meta-study divided up more than…
Read MoreMen Have Twice the Myocardial Infarction (MI) Risk Compared to Women
Men had nearly twice the risk of Myocardial Infarction (MI) compared with women even after adjusting for coronary heart disease risk factors such as serum lipid levels, blood pressure, smoking, diabetes, body mass index and physical activity, according to a study in Norway. The difference between genders remained similar throughout most of their lives, although…
Read MoreLife-Saving Medical Device, Breaks and Causes Heart Damage to Patient
SANTA ANA — A patient has filed suit against the manufacturer of a heart implantation device, alleging it was defective and damaged her heart, her kidney and caused other medical issues. Joan Wiseman filed a complaint on Aug. 22 in U.S. District Court for the Central District of California, Southern Division, against Cook Medical Inc.,…
Read MoreMedtronic, HeartWare complete $1.1 billion deal
Medtronic completed its acquisition of HeartWare International on Aug. 22, a deal intended to expand the company’s heart failure business. Medtronic agreed to pay $58.00 in cash for each outstanding share of HeartWare’s common stock. The deal is valued at approximately $1.1 billion. On June 27, Medtronic announced it had agreed to acquire HeartWare, which…
Read MoreBio2 Medical Announces 510(k) Clearance for the First Ever Angel® Catheter
GOLDEN, Colo., Aug. 24, 2016 /PRNewswire/ — Bio2 Medical is pleased to announce the Angel® Catheter has received 510(k) clearance from the United States Food & Drug Administration (FDA). This 510(k) clearance includes a first ever, prophylactic indication for a medical device to protect critically ill patients at high-risk for pulmonary embolism (PE) and contraindicated…
Read MoreStudy Of Sudden Heart Death Exposes Limits Of Genetic Testing
Scientists have discovered that a common cause of sudden heart death has been misunderstood because researchers didn’t appropriately account for racial differences in their studies. The findings, published online Wednesday in the New England Journal of Medicine,have implications far beyond this particular inherited disease, called hypertrophic cardiomyopathy, or HCM. Researchers say the results also sound…
Read MoreBoston Scientific Recalls Lotus Valve System Units for Delivery System Malfunction
MARLBOROUGH, MA — Boston Scientific has issued a voluntary global recall for several units of the Lotus Valve System because of breakage issues with the release mandrel, a component of the delivery system. Release mandrel breaks most commonly resulted in the need to resheath and remove the device, which added to procedural times, but also…
Read MoreListings for Heart Transplants Increase Since ACA Implementation
Since the implantation of the Patient Protection and Affordable Care Act (ACA) in 2014, listings for heart transplants have increased by 17 percent, according to a recent analysis. Meanwhile, listings for liver transplants and kidney transplants only increased 2 percent and 1 percent, respectively, during the same time period. Lead researcher Guilherme H. Oliveira, MD,…
Read MoreCorindus Vascular Robotics hires J. Aaron Grantham as chief medical officer
Corindus Vascular Robotics announced August 3 that it had hired J. Aaron Grantham, MD, as its chief medical officer. Grantham, an interventional cardiologist, will continue to treat patients at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri. In his new role at Corindus, Grantham will focus on educating physicians and others about the…
Read MoreReliantHeart’s aVAD Left Ventricular Assist Device Earned CE Mark
ReliantHeart’s next-generation aVAD left ventricular assist device has just earned CE Mark approval and implants are set to begin in September. ReliantHeart’s new left ventricular assist device (LVAD), the aVAD, has been approved for commercial implants in Europe. On Tuesday, the company received CE Mark approval for the aVAD. Recently profiled by MD+DI, the aVAD…
Read More